English | Español

Glaxosmithkline
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Carol Ostrow | Dec 16, 2017

Multiple myeloma study results encouraging, GSK says
Carol Ostrow | Dec 15, 2017

GSK receives FDA approval for expanded use of Nucala
Carol Ostrow | Dec 15, 2017

GSK says Shingrix promising for preventing shingles in stem cell transplant patients
Carol Ostrow | Sep 24, 2017

GlaxoSmithKline, Innoviva COPD therapy gains FDA approval
Carol Ostrow | Sep 23, 2017

Self-injectable form of Lupus therapy clears hurdle in Europe
Carol Ostrow | Sep 21, 2017

GSK’s Shingrix shingles vaccine clears an FDA hurdle

Carol Ostrow | Sep 18, 2017

Salford Lung Study shows promise for GlaxoSmithKline asthma treatment

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program